Stay updated on AbbVie Press Releases
Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest updates to the AbbVie Press Releases page
- Check4 days agoChange DetectedAdded a December 2, 2025 press release: AbbVie to Feature New Data at ASH 2025, showcasing continued advances across novel treatment modalities in multiple blood cancers. Removed the November 18, 2025 press release announcing U.S. FDA approval of EPKINLY® (epcoritamab-bysp) in combination with Rituximab and Lenalidomide for relapsed or refractory follicular lymphoma.SummaryDifference8%
- Check11 days agoChange DetectedNew press releases and related social updates have been added, including the December 01, 2025 ECLIPSE data item and the November 24, 2025 Piper Sandler conference. Older items, including Genmab references and an FDA approval note, have been removed.SummaryDifference10%
- Check18 days agoChange DetectedNew items such as the FDA approval of EPKINLY (epcoritamab-bysp) in combination with Rituximab and Lenalidomide for relapsed/refractory follicular lymphoma were added. Older entries were removed from the listing.SummaryDifference10%
- Check26 days agoChange DetectedNew November 2025 press releases and updates were added to the News Center, including partnerships, awards, and data announcements. Older items such as the earnings call alert were removed.SummaryDifference12%
- Check33 days agoChange DetectedNew social media posts with hashtags were added to the AbbVie feed. A prior investor reminder link and related content were removed.SummaryDifference7%
- Check40 days agoChange DetectedNew entries for Oct 31, 2025 and Oct 29–28, 2025 have been added to the News Center (Q3 results, Botox Day, Vitiligo topline results). The feed now includes social posts and links, with older items pruned to streamline the page.SummaryDifference12%
Stay in the know with updates to AbbVie Press Releases
Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.